Martin Williams sits down at a three-keyboard organ in the sanctuary of Park Plaza Christian Church at 32nd and Indiana streets. He pulls a couple of draw knobs for the ...

Shares of InMed Pharmaceuticals were up 71% after the company unveiled preclinical data supporting the potential of INM-901 as a therapeutic candidate in Alzheimer's disease. The stock was ...

As a founding member of the INM Industry Consortium, Flex will work together with MIT researchers, faculty and peer organizations to drive a shared vision of improving manufacturing by harnessing ...

TRAVERSE CITY — A diverse group of northern Michigan professionals actively think and talk about death – and say the rest of us would be better off doing so too.

Salanya Angel Inm was inspired to open Jai in Koreatown after years of feeling that Los Angeles lacked late-night spaces not oriented around alcohol. She wanted to create an alternative for her ...

INM vs AUM Match Details The 9th match of the International Master League 2025 will be played on March 5 at the Kotambi Stadium in Vadodara. The game is set to take place at 7:30 PM IST. The live ...

INM vs SLM: Check our Fantasy Cricket Prediction, Tips, Playing Team Picks for International Masters League T20 2025, Match 1 on February 22nd Sachin Tendulkar will be the main attraction in this ...

InMed Pharmaceuticals shares are trading higher by 45% during Tuesday's session. The company announced that INM-901 reduced Alzheimer 's-related inflammation in a preclinical study.

Improved cytokine profile - INM-901 treated groups showed a dose-dependent and statistically significant reduction in plasma pro-inflammatory cytokines such as TNF-α, IL-1ß and INF-γ.

Short interest in InMed Pharmaceuticals Corp (XNAS:INM) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.

We and our 899 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting I Accept enables tracking technologies to support the purposes shown under ...

InMed Pharmaceuticals (Nasdaq:INM) recently released preclinical data indicating its proprietary, small molecule compound, INM-901, targets multiple biological pathways associated with Alzheimer ...